Cargando…

Cardiac electrophysiological imaging systems scalable for high-throughput drug testing

Multi-parametric electrophysiological measurements using optical methods have become a highly valued standard in cardiac research. Most published optical mapping systems are expensive and complex. Although some applications demand high-cost components and complex designs, many can be tackled with si...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Peter, Wang, Ken, Woods, Christopher E., Yan, Ping, Kohl, Peter, Ewart, Paul, Loew, Leslie M., Terrar, Derek A., Bollensdorff, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513599/
https://www.ncbi.nlm.nih.gov/pubmed/23053475
http://dx.doi.org/10.1007/s00424-012-1149-0
_version_ 1782251922167693312
author Lee, Peter
Wang, Ken
Woods, Christopher E.
Yan, Ping
Kohl, Peter
Ewart, Paul
Loew, Leslie M.
Terrar, Derek A.
Bollensdorff, Christian
author_facet Lee, Peter
Wang, Ken
Woods, Christopher E.
Yan, Ping
Kohl, Peter
Ewart, Paul
Loew, Leslie M.
Terrar, Derek A.
Bollensdorff, Christian
author_sort Lee, Peter
collection PubMed
description Multi-parametric electrophysiological measurements using optical methods have become a highly valued standard in cardiac research. Most published optical mapping systems are expensive and complex. Although some applications demand high-cost components and complex designs, many can be tackled with simpler solutions. Here, we describe (1) a camera-based voltage and calcium imaging system using a single ‘economy’ electron-multiplying charge-coupled device camera and demonstrate the possibility of using a consumer camera for imaging calcium transients of the heart, and (2) a photodiode-based voltage and calcium high temporal resolution measurement system using single-element photodiodes and an optical fibre. High-throughput drug testing represents an application where system scalability is particularly attractive. Therefore, we tested our systems on tissue exposed to a well-characterized and clinically relevant calcium channel blocker, nifedipine, which has been used to treat angina and hypertension. As experimental models, we used the Langendorff-perfused whole-heart and thin ventricular tissue slices, a preparation gaining renewed interest by the cardiac research community. Using our simplified systems, we were able to monitor simultaneously the marked changes in the voltage and calcium transients that are responsible for the negative inotropic effect of the compound. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00424-012-1149-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-3513599
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-35135992012-12-05 Cardiac electrophysiological imaging systems scalable for high-throughput drug testing Lee, Peter Wang, Ken Woods, Christopher E. Yan, Ping Kohl, Peter Ewart, Paul Loew, Leslie M. Terrar, Derek A. Bollensdorff, Christian Pflugers Arch Muscle Physiology Multi-parametric electrophysiological measurements using optical methods have become a highly valued standard in cardiac research. Most published optical mapping systems are expensive and complex. Although some applications demand high-cost components and complex designs, many can be tackled with simpler solutions. Here, we describe (1) a camera-based voltage and calcium imaging system using a single ‘economy’ electron-multiplying charge-coupled device camera and demonstrate the possibility of using a consumer camera for imaging calcium transients of the heart, and (2) a photodiode-based voltage and calcium high temporal resolution measurement system using single-element photodiodes and an optical fibre. High-throughput drug testing represents an application where system scalability is particularly attractive. Therefore, we tested our systems on tissue exposed to a well-characterized and clinically relevant calcium channel blocker, nifedipine, which has been used to treat angina and hypertension. As experimental models, we used the Langendorff-perfused whole-heart and thin ventricular tissue slices, a preparation gaining renewed interest by the cardiac research community. Using our simplified systems, we were able to monitor simultaneously the marked changes in the voltage and calcium transients that are responsible for the negative inotropic effect of the compound. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00424-012-1149-0) contains supplementary material, which is available to authorized users. Springer-Verlag 2012-09-29 2012 /pmc/articles/PMC3513599/ /pubmed/23053475 http://dx.doi.org/10.1007/s00424-012-1149-0 Text en © The Author(s) 2012 https://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Muscle Physiology
Lee, Peter
Wang, Ken
Woods, Christopher E.
Yan, Ping
Kohl, Peter
Ewart, Paul
Loew, Leslie M.
Terrar, Derek A.
Bollensdorff, Christian
Cardiac electrophysiological imaging systems scalable for high-throughput drug testing
title Cardiac electrophysiological imaging systems scalable for high-throughput drug testing
title_full Cardiac electrophysiological imaging systems scalable for high-throughput drug testing
title_fullStr Cardiac electrophysiological imaging systems scalable for high-throughput drug testing
title_full_unstemmed Cardiac electrophysiological imaging systems scalable for high-throughput drug testing
title_short Cardiac electrophysiological imaging systems scalable for high-throughput drug testing
title_sort cardiac electrophysiological imaging systems scalable for high-throughput drug testing
topic Muscle Physiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513599/
https://www.ncbi.nlm.nih.gov/pubmed/23053475
http://dx.doi.org/10.1007/s00424-012-1149-0
work_keys_str_mv AT leepeter cardiacelectrophysiologicalimagingsystemsscalableforhighthroughputdrugtesting
AT wangken cardiacelectrophysiologicalimagingsystemsscalableforhighthroughputdrugtesting
AT woodschristophere cardiacelectrophysiologicalimagingsystemsscalableforhighthroughputdrugtesting
AT yanping cardiacelectrophysiologicalimagingsystemsscalableforhighthroughputdrugtesting
AT kohlpeter cardiacelectrophysiologicalimagingsystemsscalableforhighthroughputdrugtesting
AT ewartpaul cardiacelectrophysiologicalimagingsystemsscalableforhighthroughputdrugtesting
AT loewlesliem cardiacelectrophysiologicalimagingsystemsscalableforhighthroughputdrugtesting
AT terrardereka cardiacelectrophysiologicalimagingsystemsscalableforhighthroughputdrugtesting
AT bollensdorffchristian cardiacelectrophysiologicalimagingsystemsscalableforhighthroughputdrugtesting